Skip to content
Screener

West Pharmaceutical Services WST Other European countries — Net Sales

Similar metrics at other companies

Astec Industries logo
ASTEOther European Countries — Net Sales
$6.15M+3.8%
Applied Industrial Technologies logo
AITOther countries — Net Sales
$73.55M+16.9%
Graco logo
GGGOther countries — Net Sales
$267.31M+0.2%
Apple logo
AAPLOther countries — Net Sales
$50B+10.0%
McCormick & Company, Incorporated logo
MKCOther Countries — Net Sales
$350.88M+1.7%
Element Solutions logo
ESIOther countries — Net Sales
$367.25M+4.1%

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24.7B+44.8%
Enterprise value$24.58B+45.8%
P/E43.7×+8.7×
P/S7.4×+1.7×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: West Pharmaceutical Services’s 10-K, filed February 17, 2026.

Filed
Feb 17, 2026, 4:28 PM EST
Fiscal year
FY2025
Accession
0000105770-26-000010
($ in millions)Net Sales / 2025Net Sales / 2024Net Sales / 2023Long-Lived Assets / 2025Long-Lived Assets / 2024
United States$1,329.6$1,230.8$1,238.5$834.7$832.0
Germany380.3372.5406.1233.2191.1
Ireland333.3323.2285.7366.3299.6
France226.6242.2282.9113.384.7
Other European countries451.0385.5388.1108.798.1
Other353.3339.0348.5221.9210.3
$3,074.1$2,893.2$2,949.8$1,878.1$1,715.8

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is West Pharmaceutical Services's other european countries — net sales?
West Pharmaceutical Services (WST) reported other european countries — net sales of $112.75M in Q4 2025.
How has West Pharmaceutical Services's other european countries — net sales changed year-over-year?
West Pharmaceutical Services's other european countries — net sales increased by 17.0% year-over-year, from $96.38M to $112.75M.
What is the long-term trend for West Pharmaceutical Services's other european countries — net sales?
Over 4 years (2021 to 2025), West Pharmaceutical Services's other european countries — net sales has grown at a 7.2% compound annual growth rate (CAGR), from $341.3M to $451M.
What does other european countries — net sales mean?
This metric represents the total revenue generated from customers located in European countries outside of the company's primary regional hubs. It reflects the market penetration and demand for pharmaceutical packaging and delivery solutions within these specific secondary European territories. Tracking this figure helps assess the geographic diversification and growth trajectory of the company's international sales footprint.

Ask your AI about West Pharmaceutical Services's other european countries — net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude